Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riccardo Arisio

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
In Vivo (Athens, Greece)|October 31, 2019
Axillary Dissection <i>vs</i>. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution ExperienceRiccardo Arisio, Fulvio Borella, Mauro Porpiglia, et al.
Biomed Research International|August 20, 2014
Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancerGuido Valente, Federica Morani, Giuseppina Nicotra, et al.
The Pediatric Infectious Disease Journal|July 5, 2008
Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspeciesPaolo Manzoni, Marialisa Leonessa, Paolo Galletto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2006
Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breastAnna Sapino, Martino Bosco, Paola Cassoni, et al.
Experimental Cell Research|August 14, 2003
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasivenessPiera Maggiora, Annalisa Lorenzato, Stefano Fracchioli, et al.
Breast Cancer Research and Treatment|August 4, 2009
The circadian gene NPAS2 is a novel prognostic biomarker for breast cancerChunhui Yi, Lina Mu, Irene A Rigault de la Longrais, et al.
Breast Cancer Research and Treatment|May 16, 2008
Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristicsLina Mu, Dionyssios Katsaros, Andrew Wiley, et al.
International Journal of Cancer|December 13, 2002
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survivalChristian Sfiligoi, Annarita de Luca, Ilaria Cascone, et al.
Breast Cancer Research and Treatment|February 4, 2010
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancersIsabella Castellano, Elena Allia, Valeria Accortanzo, et al.
Journal of the National Cancer Institute|July 20, 2010
Functional role and prognostic significance of CD157 in ovarian carcinomaErika Ortolan, Riccardo Arisio, Simona Morone, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
In Vivo (Athens, Greece)|October 31, 2019
Axillary Dissection <i>vs</i>. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution ExperienceRiccardo Arisio, Fulvio Borella, Mauro Porpiglia, et al.
Biomed Research International|August 20, 2014
Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancerGuido Valente, Federica Morani, Giuseppina Nicotra, et al.
The Pediatric Infectious Disease Journal|July 5, 2008
Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspeciesPaolo Manzoni, Marialisa Leonessa, Paolo Galletto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2006
Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breastAnna Sapino, Martino Bosco, Paola Cassoni, et al.
Experimental Cell Research|August 14, 2003
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasivenessPiera Maggiora, Annalisa Lorenzato, Stefano Fracchioli, et al.
Breast Cancer Research and Treatment|August 4, 2009
The circadian gene NPAS2 is a novel prognostic biomarker for breast cancerChunhui Yi, Lina Mu, Irene A Rigault de la Longrais, et al.
Breast Cancer Research and Treatment|May 16, 2008
Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristicsLina Mu, Dionyssios Katsaros, Andrew Wiley, et al.
International Journal of Cancer|December 13, 2002
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survivalChristian Sfiligoi, Annarita de Luca, Ilaria Cascone, et al.
Breast Cancer Research and Treatment|February 4, 2010
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancersIsabella Castellano, Elena Allia, Valeria Accortanzo, et al.
Journal of the National Cancer Institute|July 20, 2010
Functional role and prognostic significance of CD157 in ovarian carcinomaErika Ortolan, Riccardo Arisio, Simona Morone, et al.
Pageof 4